Jonathan Benjamin
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Blood & Marrow Transplantation
- Member, Bio-X
Key Documents
Contact Information
-
Clinical Offices
Blood and Marrow Transplant Program 300 Pasteur Drive H0101, MC 5623 Stanford, CA 94305 Tel Work (650) 723-0822 Fax (650) 725-8950
- Academic Offices
Personal Information Email Tel (650) 723-0822Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Blood and Marrow Transplant
- Blood and Marrow Transplantation
- Internal Medicine
Professional Education
| Residency: | UCSF, CA USA (2003) |
| Board Certification: | Hematology, American Board of Internal Medicine (2008) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2004) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2007) |
| Fellowship: | Stanford University - BMT CA (2008) |
| Fellowship: | UCSF - Hematology CA (2007) |
Scientific Focus
Current Research Interests
My research interests adoptive transfer of defined subsets of lymphocytes for the treatment of hematologic malignancies. I have a specific interest in the treatment of Myelodysplastic Syndromes with non-myeloablative and reduced intensity transplant conditioning regimens.
Clinical Trials
- Recruiting Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
- Recruiting Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
- Recruiting Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
- Recruiting Fluticasone Propionate, Azithromycin, and Montelukast Sodium in Treating Patients With Bronchiolitis Obliterans Who Previously Underwent Stem Cell Transplant
- Recruiting Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
Publications
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood. 2012; (25): 6145-54
- Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011; (11): 1679-87
- Biology and clinical effects of natural killer cells in allogeneic transplantation. Curr Opin Oncol. 2010; (2): 130-7
- Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure. Bone Marrow Transplant. 2010; (2): 303-9
Help
Trial Administration